All News

Pharmaceutical Executive presents the 2022 APEX Awards, which is presented by a jury of HCPs for breakthroughs in pharmaceutical and healthcare marketing and communications.

Sharif has over a decade of experience working in the healthcare field.

The companies have shown a commitment to enhancing greater equity for women.

The $20 million, five-year-initiative will work to increase equity in U.S. cancer care.

Jones is credited with improving diversity at the organization.

The report details the company's efforts environmental, social, and governance areas.

The new office will give clients access to the company's services in the Chinese market.

Hogan Lovells released a survey that tracked the thinking of compliance professionals who are implementing ESG into compliance programs.

Companies headquartered in the state raised the fourth highest annual total in the first half of this year.

Costs related to health care and prescription drugs are impacting large employers.

Howard University College of Pharmacy will now offer a two-year post-professional Doctorate in Pharmacy fellowship program.

Podcast recognized for its excellence in apps and podcasts category.

Industry leaders discuss new technologies, research, and investment strategies.

Board Certified Biologics and Biosimilars Specialist (BCBBS) program will launch in 2022.

Kraus brings more than 25 years of experience leading life sciences companies, including global responsibility for customer strategy, sales, operations, and various support functions.

New accelerator will develop products and solutions with the use of digital, data, and AI.

Experienced physician with in-depth expertise in clinical development and immuno-oncology.

New senior executive brings 25 years of HR leadership and pharma industry experience.

Datavant will enable connectivity to Arcadia’s de-identified electronic health record data.

Role drift and clinical trials among many areas for compliance professionals to keep an eye on in 2022.

New data emerges from release of IQVIA's U.S. Medicines Trends 2022 Report.

Collaboration reinforces value of connecting proprietary and third-party data.

Updated guidance reflects progress of ongoing dialog between biopharma companies and investors toward achieving more effective ESG communications.

FDA recently approved the disease-modifying therapy for adults with hemolytic anemia caused by PK (pyruvate kinase) deficiency.

Acquisition will extend UBC's services to include an affordability solution.

ESG Evaluation names Sanofi as one of the most sustainability-committed companies.

Three pharma companies represented in top 100.

Partnership will utilize Medable's trial software platform to enhance access.

COVID-19 response, global workforce both among highlights.